Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Statistics

Total Valuation

FENC has a market cap or net worth of $127.51 million. The enterprise value is $116.24 million.

Market Cap	127.51M
Enterprise Value	116.24M

Important Dates

The next confirmed earnings date is Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

FENC has 27.42 million shares outstanding. The number of shares has increased by 7.70% in one year.

Shares Outstanding	27.42M
Shares Change (YoY)	+7.70%
Shares Change (QoQ)	-12.20%
Owned by Insiders (%)	1.81%
Owned by Institutions (%)	23.00%
Float	14.81M

Valuation Ratios

The trailing PE ratio is 48.69 and the forward PE ratio is 35.09.

PE Ratio	48.69
Forward PE	35.09
PS Ratio	2.56
Forward PS	2.12
PB Ratio	n/a
P/FCF Ratio	5.53
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	42.50
EV / Sales	2.38
EV / EBITDA	n/a
EV / EBIT	19.81
EV / FCF	5.05

Financial Position

The company has a current ratio of 8.02

Current Ratio	8.02
Quick Ratio	7.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	1.38
Interest Coverage	1.45

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	8.88%
Return on Capital (ROIC)	15.92%
Revenue Per Employee	$1.69M
Profits Per Employee	$94,310
Employee Count	29
Asset Turnover	1.18
Inventory Turnover	1.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.61% in the last 52 weeks. The beta is 0.27, so FENC's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-32.61%
50-Day Moving Average	4.93
200-Day Moving Average	7.42
Relative Strength Index (RSI)	49.88
Average Volume (20 Days)	74,112

Short Selling Information

The latest short interest is 1.84 million, so 6.71% of the outstanding shares have been sold short.

Short Interest	1.84M
Short Previous Month	1.85M
Short % of Shares Out	6.71%
Short % of Float	12.43%
Short Ratio (days to cover)	21.88

Income Statement

In the last 12 months, FENC had revenue of $48.89 million and earned $2.74 million in profits. Earnings per share was $0.10.

Revenue	48.89M
Gross Profit	46.72M
Operating Income	5.87M
Pretax Income	3.75M
Net Income	2.74M
EBITDA	n/a
EBIT	5.87M
Earnings Per Share (EPS)	$0.10

Balance Sheet

The company has $43.05 million in cash and $31.79 million in debt, giving a net cash position of $11.27 million or $0.41 per share.

Cash & Cash Equivalents	43.05M
Total Debt	31.79M
Net Cash	11.27M
Net Cash Per Share	$0.41
Equity (Book Value)	-1.36M
Book Value Per Share	-0.05
Working Capital	54.42M

Cash Flow

Operating Cash Flow	23.04M
Capital Expenditures	n/a
Free Cash Flow	23.04M
FCF Per Share	$0.84

Margins

Gross margin is 95.55%, with operating and profit margins of 12.00% and 5.59%.

Gross Margin	95.55%
Operating Margin	12.00%
Pretax Margin	5.59%
Profit Margin	5.59%
EBITDA Margin	n/a
EBIT Margin	12.00%
FCF Margin	61.13%

Dividends & Yields

FENC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.70%
Shareholder Yield	-7.70%
Earnings Yield	2.14%
FCF Yield	18.07%

Analyst Forecast

The average price target for FENC is $14.00, which is 201.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	201.08%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	50.28%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on September 5, 2014. It was a reverse split with a ratio of 0.3333333:1.

Last Split Date	Sep 5, 2014
Split Type	Reverse
Split Ratio	0.3333333:1

Scores

FENC has an Altman Z-Score of -0.41 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.41
Piotroski F-Score	7